Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Outcomes of Anti-PD1 Treatment for Relapsed/Refractory Hodgkin Lymphoma: A German Hodgkin Study Group (GHSG) Multi-Center Real-World Analysis

Blood (2021) 138 (Supplement 1): 4533.

https://doi.org/10.1182/blood-2021-153200

Published: 2021

Journal Articles

A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL

Blood (2021) 137 (19): 2646–2656.

https://doi.org/10.1182/blood.2020008825

Published: 2021

Includes: Supplemental data

Journal Articles

Early Allogeneic Blood Stem Cell Transplantation after Melphalan-Induced Aplasia for Patients with Primary Refractory or Relapsed Acute Myeloid Leukemia - Results of a Retrospective Single Center Analysis

Kerstin Schaefer-Eckart, MD, Knut Wendelin, MD, Sabine Dressler, MD, Starke Martina, MD, Martin Wilhelm, MD PhD

Blood (2016) 128 (22): 5839.

https://doi.org/10.1182/blood.V128.22.5839.5839

Published: 2016

Journal Articles

Romidepsin Induces Durable Responses in Patients with Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL)

Barbara Pro, MD, Steven M. Horwitz, MD, H. Miles Prince, MB BS (Hons) MDFRACP FRCPA AFRACMA MACD, Francine M. Foss, MD, Lubomir Sokol, MD PhD, Matthew Greenwood, MD FRACP, FRCPA, Dolores Caballero, Franck Morschhauser, MD PhD, Martin Wilhelm, MD, Lauren Pinter-Brown, Prof, MD FACP, Swaminathan Padmanabhan Iyer, MD Dir, Hematological Malignancies, Andrei R. Shustov, MD, Julie Wolfson, MPH, Barbara E Balser, VMD, Bertrand Coiffier, MD PhD Prof

Blood (2014) 124 (21): 1742.

https://doi.org/10.1182/blood.V124.21.1742.1742

Published: 2014

Journal Articles

Consolidation Therapy Is Associated with Significantly Lower Bleeding Risk Compared to Induction Therapy in Patients with Acute Myeloid Leukemia

Kerstin Schaefer-Eckart, MD, Knut Wendelin, MD, Bettina Pilz, Michael Kramer, PhD, Gerhard Ehninger, MD, Martin Wilhelm, MD PhD, Hannes Wandt, MD

Blood (2014) 124 (21): 3686.

https://doi.org/10.1182/blood.V124.21.3686.3686

Published: 2014

Journal Articles

Evaluation Of Myeloablative Therapy Followed By Autologous Stem Cell Transplantation In First Remission In Patients With Advanced Stage Follicular Lymphoma After Initial Immuno-Chemotherapy (R-CHOP) Or Chemotherapy Alone: Analysis Of 940 Patients Treated In Prospective Randomized Trials Of The German Low Grade Lymphoma Study Group (GLSG)

Wolfgang Hiddemann, M.D., Martin H. Dreyling, M.D. Ph.D., Bernd Metzner, M.D., Michael Pfreundschuh, M.D. Ph.D., Martin Wilhelm, M.D. Ph.D., Eva Lengfelder, M.D. Ph.D., Georg Hess, M.D. Ph.D., Michael Hallek, M.D. Ph.D., Norbert Schmitz, M.D. Ph.D., Christiane Pott, M.D. Ph.D., Thomas Fischer, M.D. Ph.D., Roswitha Forstpointner, M.D., Eva Hoster, Ph.D., Michael Unterhalt, M.D. Ph.D.

Blood (2013) 122 (21): 419.

https://doi.org/10.1182/blood.V122.21.419.419

Published: 2013

Journal Articles

Romidepsin Induces Durable Responses in Patients with Peripheral T-Cell Lymphoma: GPI-06–0002 Study Update

Bertrand Coiffier, MD, PhD, Barbara Pro, MD, Miles Prince, MD, FRACP, FRCPA, Francine M. Foss, MD, Lubomir Sokol, MD, Ph.D, Matthew Greenwood, MD, FRACP, FRCPA, Dolores Caballero, MD, Franck Morschhauser, MD, PhD, Martin Wilhelm, MD, Lauren Pinter-Brown, MD, Swaminathan Padmanabhan, MD, Andrei R. Shustov, MD, Tina Nielsen, MD, PhD, Jean Nichols, PhD, Julie Wolfson, MPH, Barbara E Balser, VMD, Steven M. Horwitz, MD

Blood (2012) 120 (21): 3641.

https://doi.org/10.1182/blood.V120.21.3641.3641

Published: 2012

Journal Articles

CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study

Raoul Herbrecht, David MacDonald, MD, FRCPC, Florian Weissinger, MD, Martin Wilhelm, MD, Charles Holladay, MS, MD, Nam H. Dang, MD, PhD, Peter Holman, MD, Paul Cernohous, MS, Jack Singer, MD, Richard H. van der Jagt, MD, FRCPC

Blood (2011) 118 (21): 1605.

https://doi.org/10.1182/blood.V118.21.1605.1605

Published: 2011

Journal Articles

Analysis of Patients with Common Peripheral T-Cell Lymphoma Subtypes From a Phase 2 Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma

Bertrand Coiffier, MD, Barbara Pro, MD, H. Miles Prince, MBBS, FRACP, FRCPA, MD, Francine M. Foss, MD, Lubomir Sokol, MD, PhD, Matthew Greenwood, MD, FRCPA, FRACP, Dolores Caballero, MD, Peter Borchmann, MD, Franck Morschhauser, MD, PhD, Martin Wilhelm, MD, Lauren Pinter-Brown, Swaminathan Padmanabhan, MBBS, MD, Andrei R. Shustov, MD, Jean Nichols, PhD, Susan Carroll, John Balser, PhD, Steven M. Horwitz, MD

Blood (2011) 118 (21): 591.

https://doi.org/10.1182/blood.V118.21.591.591

Published: 2011

Journal Articles

A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation

André Tichelli, Hubert Schrezenmeier, Gérard Socié, Judith Marsh, Andrea Bacigalupo, Ulrich Dührsen, Anke Franzke, Michael Hallek, Eckhard Thiel, Martin Wilhelm, Britta Höchsmann, Alain Barrois, Kim Champion, Jakob R. Passweg

Blood (2011) 117 (17): 4434–4441.

https://doi.org/10.1182/blood-2010-08-304071

Published: 2011

Includes: Supplemental data

Journal Articles

Final Results From a Pivotal, Multicenter, International, Open-Label, Phase 2 Study of Romidepsin In Progressive or Relapsed Peripheral T-Cell Lymphoma (PTCL) Following Prior Systemic Therapy

Bertrand Coiffier, MD, PhD, Barbara Pro, MD, H. Miles Prince, MD, FRACP, FRCPA, Francine M Foss, MD, Lubomir Sokol, MD, PhD, Matthew Greenwood, MD, FRCPA, FRACP, Dolores Caballero, MD, Peter Borchmann, MD, Franck Morschhauser, MD, PhD, Martin Wilhelm, MD, Lauren Pinter-Brown, MD, Swaminathan Padmanabhan, MD, Andrei Shustov, MD, Jean Nichols, Susan Carroll, John Balser, PhD, Steven M Horwitz, MD

Blood (2010) 116 (21): 114.

https://doi.org/10.1182/blood.V116.21.114.114

Published: 2010

Journal Articles

Use of G-CSF in Patients with Severe Aplastic Anemia Treated with ATG and Cyclosporine Increases Neutrophils and Decreases Infection Rates and Hospitalization Days but Does Not Improve Long-Term Outcome: Results of a Prospective, Randomized Clinical Trial of the EBMT.

AndrÉ Tichelli, Hubert Schrezenmeier, Gerard Socié, Judith Marsh, Andrea Bacigalupo, Ulrich Duehrsen, Anke Franzke, Michael Hallek, Eckhard Thiel, Martin Wilhelm, Britta Höchsmann, Alain Barrois, Kim Champion, Jakob R. Passweg

Blood (2009) 114 (22): 496.

https://doi.org/10.1182/blood.V114.22.496.496

Published: 2009

Journal Articles

Mito-FLAG with Ara-C as Bolus Vs. Continuous Infusion in Recurrent AML – Results of a Prospective Randomized Intergroup Study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemias (SAL)

Mathias Hanel, Kai Friedrichsen, Frank Kroschinsky, Wolfram Poenisch, Kerstin Schaefer-Eckart, Walter Aulitzky, Norma Peter, Sascha Neugebauer, Regina Herbst, Annette Hanel, Martin Wilhelm, Dietger Niederwieser, Gerhard Ehninger, Friedrich Fiedler

Blood (2008) 112 (11): 2972.

https://doi.org/10.1182/blood.V112.11.2972.2972

Published: 2008

Journal Articles

Allogeneic Stem Cell Transplantation with Dose-Reduced Conditioning in Relapsed Follicular and Mantle Cell Lymphoma - A Prospective Phase II Trial of the German Low Grade Lymphoma Study Group (GLSG).

Martin H. Dreyling, D.-W. Beelen, Michael Schleuning, Anthony D. Ho, Martin Gramatzki, B. Glas, Michael Pfreundschuh, Martin Wilhelm, Norbert Schmitz, Hans-Jochem Kolb, Michael Unterhalt, Wolfgang Hiddemann

Blood (2007) 110 (11): 3058.

https://doi.org/10.1182/blood.V110.11.3058.3058

Published: 2007

Journal Articles

Different Outcome for Angioimmunoblastic T-Cell Lymphoma (AIL) and Peripheral T-Cell Lymphoma Unspecified (PTCL-U) Following Upfront Autologous Stem Cell Transplantation.

Peter Reimer, MD, Thomas Ruediger, MD, Florian Weissinger, MD, Hans Konrad Mueller-Hermelink, Andreas Engert, Hermann Einsele, Martin Wilhelm

Blood (2006) 108 (11): 5431.

https://doi.org/10.1182/blood.V108.11.5431.5431

Published: 2006

Journal Articles

Interim Analysis of a Prospective Randomised Study Comparing a Therapeutic Platelet Transfusion Strategy with the Prophylactic Platelet Transfusion Standard in Patients after Autologous Peripheral Stem Cell Transplantation (ASCT).

Kerstin Schaefer-Eckart, MD, Knut Wendelin, MD, Martin Wilhelm, MD, PhD, U. Mahlknecht, MD, R. Conradi, MD, M. Schaich, MD, L. Leimer, MD, Hannes Wandt, MD

Blood (2006) 108 (11): 577.

https://doi.org/10.1182/blood.V108.11.577.577

Published: 2006

Journal Articles

Results of a Phase II Study of Pixantrone in Combination with Cyclophosphamide, Vincristine, and Prednisone in Patients with Relapsed Aggressive Non-Hodgkin’s Lymphoma.

Peter Borchmann, MD, Raoul Herbrecht, MD, Martin Wilhelm, Franck Morschhauser, MD, Georg Hess, MD, Klaus Kutz, Scott Stromatt, MD, Andreas Engert, MD

Blood (2006) 108 (11): 529.

https://doi.org/10.1182/blood.V108.11.529.529

Published: 2006

Journal Articles

Inhibition of γδ T Cell Proliferation by CD4 + CD25 + FOXP3 + Regulatory T Cells (Treg).

Volker Kunzmann, MD, Brigitte Kimmel, PhD, Judith Engert, Martin Wilhelm, MD, Hermann Einsele, MD

Blood (2006) 108 (11): 1742.

https://doi.org/10.1182/blood.V108.11.1742.1742

Published: 2006

Journal Articles

Clinical-Scale Combined CD4/CD8 Depletion for Donor Innate Lymphocyte Infusion (DILI).

Volker Kunzmann, MD, Manfred Smetak, PhD, Florian Weissinger, MD, Josef Birkmann, MD, Hermann Einsele, MD, Martin Wilhelm, MD

Blood (2006) 108 (11): 3657.

https://doi.org/10.1182/blood.V108.11.3657.3657

Published: 2006

Journal Articles

Autologous Stem Cell Transplantation as First-Line Therapy in Peripheral T-Cell Lymphomas. A Prospective Multicenter Study.

Peter Reimer, MD, Thomas Ruediger, MD, Tobias Schertlin, MD, Eva Geissinger, MD, Florian Weissinger, MD, Hermann Einsele, Hans Konrad Mueller-Hermelink, Martin Wilhelm

Blood (2005) 106 (11): 2074.

https://doi.org/10.1182/blood.V106.11.2074.2074

Published: 2005

NARROW

Outcomes of Anti-PD1 Treatment for Relapsed/Refractory Hodgkin Lymphoma: A German Hodgkin Study Group (GHSG) Multi-Center Real-World Analysis

A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL

Early Allogeneic Blood Stem Cell Transplantation after Melphalan-Induced Aplasia for Patients with Primary Refractory or Relapsed Acute Myeloid Leukemia - Results of a Retrospective Single Center Analysis

Romidepsin Induces Durable Responses in Patients with Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL)

Consolidation Therapy Is Associated with Significantly Lower Bleeding Risk Compared to Induction Therapy in Patients with Acute Myeloid Leukemia

Romidepsin Induces Durable Responses in Patients with Peripheral T-Cell Lymphoma: GPI-06–0002 Study Update

CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study

Analysis of Patients with Common Peripheral T-Cell Lymphoma Subtypes From a Phase 2 Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma

A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation

Final Results From a Pivotal, Multicenter, International, Open-Label, Phase 2 Study of Romidepsin In Progressive or Relapsed Peripheral T-Cell Lymphoma (PTCL) Following Prior Systemic Therapy

Use of G-CSF in Patients with Severe Aplastic Anemia Treated with ATG and Cyclosporine Increases Neutrophils and Decreases Infection Rates and Hospitalization Days but Does Not Improve Long-Term Outcome: Results of a Prospective, Randomized Clinical Trial of the EBMT.

Mito-FLAG with Ara-C as Bolus Vs. Continuous Infusion in Recurrent AML – Results of a Prospective Randomized Intergroup Study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemias (SAL)

Allogeneic Stem Cell Transplantation with Dose-Reduced Conditioning in Relapsed Follicular and Mantle Cell Lymphoma - A Prospective Phase II Trial of the German Low Grade Lymphoma Study Group (GLSG).

Different Outcome for Angioimmunoblastic T-Cell Lymphoma (AIL) and Peripheral T-Cell Lymphoma Unspecified (PTCL-U) Following Upfront Autologous Stem Cell Transplantation.

Interim Analysis of a Prospective Randomised Study Comparing a Therapeutic Platelet Transfusion Strategy with the Prophylactic Platelet Transfusion Standard in Patients after Autologous Peripheral Stem Cell Transplantation (ASCT).

Results of a Phase II Study of Pixantrone in Combination with Cyclophosphamide, Vincristine, and Prednisone in Patients with Relapsed Aggressive Non-Hodgkin’s Lymphoma.

Inhibition of γδ T Cell Proliferation by CD4 + CD25 + FOXP3 + Regulatory T Cells (Treg).

Clinical-Scale Combined CD4/CD8 Depletion for Donor Innate Lymphocyte Infusion (DILI).

Autologous Stem Cell Transplantation as First-Line Therapy in Peripheral T-Cell Lymphomas. A Prospective Multicenter Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only